View Cart (0 items)

Pharmaceutical

Another Ranbaxy facility lands on FDA blacklist

No Comments
The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More

Novo Nordisk locked in legal battle over generic drug

No Comments
Danish pharmaceutical giant Novo Nordisk is being sued by several healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market.
Read More

US pharmaceutical spending slightly down from 2012 levels

No Comments
Expenditure on pharmaceuticals in 2013 is predicted to register a minor decline of 0.5% dipping to $341.2 billion from $343 billion in 2012.
Read More

Global spending on medicines to grow by up to 6% per year through 2017

No Comments
The key factors that will drive global drug markets are better access to medicines due to rising disposable income in developing countries and more favorable economic conditions in emerging markets.
Read More

FDA imposes new ban on Wockhardt drugs

No Comments
Indian generic drug maker Wockhardt has been hit by a U.S. import alert for the second time this year.
Read More

FDA seeks to ban dietary supplements unlawfully marketed as drugs

No Comments
The U.S. Food and Drug Administration has taken administrative action against a dietary supplement manufacturer following multiple breaches of the Federal Food, Drug and Cosmetic Act.
Read More

Generics dent market share of brand-name drugs

No Comments
The growth of the generic drug market worldwide may turn out to be a long-term trend, experts say, as a number of studies show a stable decline in prescriptions of brand-name drugs last year.
Read More

FDA publishes finalized guidance on medical apps

No Comments
The FDA will not be regulating the majority of medical apps because they pose very little health risk to patients, but will instead adopt a "risk-based approach."
Read More

FDA tightens grip on Indian drug makers

No Comments
The U.S. Food and Drug Administration (FDA) has warned two Indian pharmaceutical companies over suspected breaches of good manufacturing practices.
Read More

FDA reiterates warning over NuVision's sterile products

No Comments
The U.S. Food and Drug Administration (FDA) has issued another alert over sterile products manufactured by Dallas-based NuVision Pharmacy.
Read More